Company Overview and News

 
Osisko Closes Financing on Victoria Gold’s Eagle Gold Project

2018-04-16 globenewswire
MONTRÉAL, April 16, 2018 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (TSX:OR) (NYSE:OR) (“Osisko”) is pleased to announce that it has completed the previously announced C$148 million financing transaction (the “Financing”) with Victoria Gold Corp. (TSX-V:VIT) (“Victoria”), pursuant to which Osisko acquired from Victoria a 5% net smelter return (“NSR”) royalty (the “Royalty”) for C$98 million (the “Royalty Purchase”) on the Dublin Gulch property (the “Property”) which hosts the Eagle Gold project located in Yukon, Canada, and purchased from Victoria, on a private placement basis, 100 million common shares of Victoria at a price of C$0.
Upvote Downvote

 
Early Warning News Release

2018-04-02 marketwired
MONTRÉAL, QUÉBEC--(Marketwired - April 2, 2018) - Osisko Gold Royalties Ltd (TSX:OR)(NYSE:OR) ("Osisko") announces that it has subscribed for and received from Niobay Metals Inc. (TSX VENTURE:NBY) ("Niobay") 9,000,000 common shares of Niobay at a price of $0.26 per share by way of a private placement of Niobay, for an aggregate subscription price of $2,340,000 (the "Private Placement"').
Upvote Downvote

 
Globex: Falco Begins 2018 Donalda Mine Drill Program

2018-03-13 marketwired
ROUYN-NORANDA, QUÉBEC--(Marketwired - March 13, 2018) - GLOBEX MINING ENTERPRISES INC. (TSX:GMX)(FRANKFURT:G1MN)(STUTTGART:G1MN)(BERLIN:G1MN)(MUNICH:G1MN)(XETRA:G1MN)(OTCQX:GLBXF) is pleased to report that Falco Resources Ltd. (TSX VENTURE:FPC) ("Falco") has commenced its 2018 exploration program on Globex's Donalda royalty property (See Globex press release dated September 27, 2017). An initial program of 10 holes for a total of 10,000 meters is planned.
Upvote Downvote

 
Osisko Acquires Gold Royalty on Victoria Gold's Fully-Financed, Shovel-Ready Eagle Gold Project in Canada

2018-03-08 marketwired
MONTRÉAL, QUÉBEC--(Marketwired - March 8, 2018) - Osisko Gold Royalties Ltd ("Osisko") (TSX:OR)(NYSE:OR) is pleased to announce that it has signed a term sheet (the "Term Sheet") with Victoria Gold Corp. ("Victoria") to acquire a 5% net smelter return ("NSR") royalty (the "Royalty") for C$98 million (the "Royalty Purchase") on the Dublin Gulch property (the "Property") which hosts the Eagle Gold project ("Eagle" or the "Project") located in Yukon, Canada ("Royalty").
Upvote Downvote

 
Falco Begins 2018 Donalda - Quemont East Drilling Program

2018-02-28 marketwired
MONTREAL, QC--(Marketwired - February 28, 2018) - Falco Resources Ltd. (TSX VENTURE: FPC) ("Falco" or the "Company") is pleased to announce that it has commenced its 2018 exploration program on the Donalda - Quemont East target. An initial program of 20 holes for a total of 20,000 metres is planned to be completed.
Upvote Downvote

1
Osisko Gold Royalties Reports Fourth Quarter and Full Year 2017 Results

2018-02-20 marketwired
MONTREAL, QUEBEC--(Marketwired - Feb. 20, 2018) - Osisko Gold Royalties Ltd (the "Company" or "Osisko") (TSX:OR)(NYSE:OR) is pleased to report its results for the fourth quarter and full year 2017 and provide 2018 guidance. Amounts are in Canadian dollars unless otherwise noted.
Upvote Downvote

 
Osisko Declares 14th Quarterly Dividend

2018-02-20 marketwired
MONTREAL, QUEBEC--(Marketwired - Feb. 20, 2018) - Osisko Gold Royalties Ltd ("Osisko" or the "Company") (TSX:OR) (NYSE:OR) is pleased to announce a first quarter 2018 dividend of C$0.05 per common share. The dividend will be paid on April 16, 2018 to shareholders of record as of the close of business on March 30, 2018.
Upvote Downvote

 
Early Warning News Release

2018-02-17 marketwired
MONTRÉAL, QUÉBEC--(Marketwired - Feb. 16, 2018) - Osisko Gold Royalties Ltd (TSX:OR)(NYSE:OR) ("Osisko") announces that, pursuant to the terms of a share purchase agreement entered into with Alamos Gold Inc. on February 16, 2018, Osisko has acquired direct ownership of 25,300,000 common shares of Corex Gold Corporation ("Corex Gold") at a price of $0.13 per common share (the "Transaction").
Upvote Downvote

 
Early Warning News Release

2018-02-06 marketwired
MONTRÉAL, QUÉBEC--(Marketwired - Feb. 6, 2018) - Osisko Gold Royalties Ltd (TSX:OR) (NYSE:OR) ("Osisko") announces that it has subscribed for and received from Algold Resources Ltd. ("Algold") 14,285,714 units of Algold at a price of $0.14 per unit (the "Units") by way of a private placement of Algold, for an aggregate subscription price of $1,999,999.96 (the "Private Placement"').
Upvote Downvote

 
Osisko Gold Royalties Updates Notice of Fourth Quarter and Full Year 2017 Results and Conference Call Details

2018-01-19 marketwired
MONTREAL, QUÉBEC--(Marketwired - Jan. 19, 2018) - Osisko Gold Royalties Ltd (the "Corporation" or "Osisko") (TSX:OR)(NYSE:OR) announces that its fourth quarter and full year 2017 results will be released before market on Tuesday, February 20, 2018 followed by a conference call the same day, February 20, 2018 at 11:00 am EDT.
Upvote Downvote

 
Osisko Announces Record 2017 Gold Equivalent Ounces

2018-01-18 marketwired
MONTREAL, QUEBEC--(Marketwired - Jan. 18, 2018) - Osisko Gold Royalties Ltd (the "Company" or "Osisko") (TSX:OR)(NYSE:OR) is pleased to announce its preliminary 2017 gold equivalent ounces ("GEOs")1.
Upvote Downvote

 
Globex: Drill Results Pending on Donalda Gold Mine Property

2018-01-10 marketwired
ROUYN-NORANDA, QUÉBEC--(Marketwired - Jan. 10, 2018) - GLOBEX MINING ENTERPRISES INC. (TSX:GMX)(FRANKFURT:G1MN)(STUTTGART:G1MN)(BERLIN:G1MN)(MUNICH:G1MN)(XETRA:G1MN)(OTCQX:GLBXF) is pleased to provide shareholders with an update on exploration by Falco Resources Limited (FPC-TSXV) on Globex's Donalda Royalty Property. Shareholders are reminded that Globex sold the former Donalda Gold Mine property to Falco in September 2017 for $300,000, 350,000 Falco shares, 350,000 five year Falco warrants and a 2.
Upvote Downvote

 
Falco Updates on Horne 5 Project Development and Exploration Activities

2018-01-10 marketwired
MONTREAL, QC--(Marketwired - January 10, 2018) - Falco Resources Ltd. (TSX VENTURE: FPC) ("Falco" or the "Company") is pleased to provide the following update on its development of the Horne 5 Project (the "Project"), exploration and corporate activities.
Upvote Downvote

1
Osisko Portfolio Update

2018-01-09 marketwired
MONTRÉAL, QUÉBEC--(Marketwired - Jan. 9, 2018) - Osisko Gold Royalties Ltd (the "Company" or "Osisko") (TSX:OR)(NYSE:OR) is pleased to provide an update on its investment portfolio. The Company reports that it has delivered its shares of AuRico Metals Inc. ("AuRico") to Centerra Gold Inc. for a $1.80 cash consideration per share and for proceeds of $25.5 million, generating a gain for Osisko of $15.
Upvote Downvote

 
Falco Strengthens Management Team

2018-01-08 marketwired
MONTREAL, QC--(Marketwired - January 08, 2018) - Falco Resources Ltd. (TSX VENTURE: FPC) ("Falco" or the "Company") is pleased to announce the appointment of Mr. Ronald Bougie to the position of Vice President Engineering and Construction and Mr. Guy Belleau to Mine General Manager for the Horne 5 Project.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...